{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:50:16Z","timestamp":1793717416230,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009104","name":"University of Modena and Reggio Emilia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2024.e24196","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T12:08:32Z","timestamp":1704456512000},"page":"e24196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells"],"prefix":"10.1016","volume":"10","author":[{"given":"Sara","family":"Ceccacci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Caroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Marani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Anceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Mozzicafreddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pellati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-2909","authenticated-orcid":false,"given":"Maria Chiara","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e24196_bib1","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/anie.201208749","article-title":"Target identification for small bioactive molecules: finding the needle in the haystack","volume":"52","author":"Ziegler","year":"2013","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.heliyon.2024.e24196_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nchembio.216","article-title":"Target profiling of small molecules by chemical proteomics","volume":"5","author":"Rix","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.heliyon.2024.e24196_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/cb100294v","article-title":"Identification of direct protein targets of small molecules","volume":"6","author":"Lomenick","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.heliyon.2024.e24196_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-2269-7_22","article-title":"Drug Affinity Responsive Target Stability (DARTS) for small-molecule target identification","volume":"1263","author":"Pai","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e24196_bib5","doi-asserted-by":"crossref","first-page":"E846","DOI":"10.3390\/biom10060846","article-title":"Carbamoyl-phosphate synthase 1 as a novel target of phomoxanthone A, a bioactive fungal metabolite","volume":"10","author":"Ceccacci","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.heliyon.2024.e24196_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105168","article-title":"M.C. Novel insights on the molecular mechanism of action of the anti-angiogenic pyrazolyl-urea GeGe-3 by functional proteomics","volume":"115","author":"Morretta","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.heliyon.2024.e24196_bib7","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/nbt.2999","article-title":"Global analysis of protein structural changes in complex proteomes","volume":"32","author":"Feng","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.heliyon.2024.e24196_bib8","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1038\/nprot.2017.100","article-title":"Measuring protein structural changes on a proteome-wide scale using limited proteolysis-coupled mass spectrometry","volume":"12","author":"Schopper","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.heliyon.2024.e24196_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nmeth.2015","article-title":"Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions","volume":"9","author":"Picotti","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.heliyon.2024.e24196_bib10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.bmc.2015.01.059","article-title":"Cannabidiol (CBD) and its analogs: a review of their effects on inflammation","volume":"23","author":"Burstein","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e24196_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13710","article-title":"A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)","volume":"130","author":"Peng","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.heliyon.2024.e24196_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e24196_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220025","article-title":"Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: an in Silico study","volume":"14","author":"Chung","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e24196_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/ptr.7357","article-title":"Chemical characterization of non-psychoactive Cannabis sativa L. extracts, in vitro antiproliferative activity and induction of apoptosis in chronic myelogenous leukaemia cancer cells","volume":"36","author":"Anceschi","year":"2022","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2024.e24196_bib15","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","article-title":"In-gel digestion for mass spectrometric characterization of proteins and proteomes","volume":"1","author":"Shevchenko","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.heliyon.2024.e24196_bib16","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e24196_bib17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41422-019-0143-x","article-title":"Structures of the human spliceosomes before and after release of the ligated exon","volume":"29","author":"Zhang","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.heliyon.2024.e24196_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminf."},{"key":"10.1016\/j.heliyon.2024.e24196_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2015.04.011","article-title":"Environmental pollutants directly affect the liver X receptor alpha activity: kinetic and thermodynamic characterization of binding","volume":"152","author":"Mozzicafreddo","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e24196_bib20","doi-asserted-by":"crossref","first-page":"12863","DOI":"10.1039\/C8CC07692H","article-title":"Chemoproteomic fishing identifies arzanol as a positive modulator of brain glycogen phosphorylase","volume":"54","author":"Del Gaudio","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.heliyon.2024.e24196_bib21","doi-asserted-by":"crossref","first-page":"W270","DOI":"10.1093\/nar\/gkr366","article-title":"SwissDock, a protein-small molecule docking web service based on EADock DSS","volume":"39","author":"Grosdidier","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e24196_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab294","article-title":"Plip 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e24196_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03040-5","article-title":"EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3","volume":"11","author":"Tu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e24196_bib24","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1128\/MCB.25.17.7432-7440.2005","article-title":"Role of Stat3 in regulating p53 expression and function","volume":"25","author":"Niu","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e24196_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ajhg.2011.12.023","article-title":"Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly","volume":"90","author":"Lines","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.heliyon.2024.e24196_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12881-020-01121-y","article-title":"A de novo synonymous variant in EFTUD2 disrupts normal splicing and causes mandibulofacial dysostosis with microcephaly: case report","volume":"21","author":"Jacob","year":"2020","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.heliyon.2024.e24196_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228909","article-title":"Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro","volume":"15","author":"Milian","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e24196_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e24196_bib29","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/onc.2013.533","article-title":"Hallmarks of alternative splicing in cancer","volume":"33","author":"Oltean","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2024.e24196_bib30","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41385-019-0184-y","article-title":"Spliceosome protein Eftud2 promotes colitis-associated tumorigenesis by modulating inflammatory response of macrophage","volume":"12","author":"Lv","year":"2019","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.heliyon.2024.e24196_bib31","first-page":"4293","article-title":"High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer Cancer","volume":"149","author":"Beyer","year":"2023","journal-title":"Res Clin Oncol"},{"key":"10.1016\/j.heliyon.2024.e24196_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41419-020-03040-5","article-title":"J. Hong EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3","volume":"11","author":"Tu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.heliyon.2024.e24196_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12094-021-02673-y","article-title":"Over-activation of EFTUD2 correlates with tumor propagation and poor survival outcomes in hepatocellular carcinoma","volume":"24","author":"Lv","year":"2022","journal-title":"Clin. Transl. Oncol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024002275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024002275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:22:20Z","timestamp":1790655740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024002275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844024002275"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24196","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A label free chemoproteomic-based platform to disclose cannabidiol molecular mechanism of action on chronic myelogenous leukemia cancer cells","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e24196"}}